Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil dose-ranging in moderate to severe obstructive sleep apnea
2005-003789-40Phase 2Active
- Sponsor
- Pharmapnea
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of donepezil in obstructive sleep apnea hypopnea syndrome (OSAHS) (4 arms), sponsored by Pharmapnea. Primary endpoint: Primary outcome variables. Started Sep 2005; status: active.
02
Drugs
donepezil
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2005-003789-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003789-40.